Their investigation of genes associated with AKR1B10 led to the discovery that the tumor-promoting function of methyltransferase 3 (METTL3) relied on the N6-methyladenosine (m6A) modification of AKR1B10. This evidence concerns the gene AKR1B10 and neoplasm.